GlucoTrack (GCTK) vs NexGel (NXGL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
GlucoTrack is the larger company by market cap ($1.0 million vs $97,622), about 10.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GCTK | NXGL |
|---|---|---|
| Share price | $1.03 | $0.2003 |
| Market cap | $1.05M | $97.62K |
| 1-day change | -7.21% | +33.53% |
| EPS (TTM) | $-114.23 | $-19.83 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $123.75 | $57.00 |
| 52-week low | $1.00 | $0.151 |
| Distance from 52-week high | -99.17% | -99.65% |
| Analyst consensus | — | hold |
| Average volume | 2.06M | 37.86K |
| Shares outstanding | 1.02M | 487.38K |
| Employees | 15 | 19 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GlucoTrack is about 10.7 times larger than NexGel by market value ($1.05M vs $97.62K).
About GlucoTrack
GCTK stock →GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Health Care · Medical/Dental Instruments · 15 employees
About NexGel
NXGL stock →NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States.
Health Care · Medical/Dental Instruments · 19 employees
GCTK vs NXGL FAQ
Which is bigger, GlucoTrack or NexGel?
GlucoTrack (GCTK) is larger, with a market capitalization of $1.05M compared with $97.62K for NexGel (NXGL).
Are GlucoTrack and NexGel in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.